Jump to any asset
850 assets, updated daily
As of September 11, 2026, ARK Innovation ETF (ARKK) trades at $83.06. RSI at 50 is in neutral territory, and the price is above its 50-day average of $80.03.
ARK Innovation ETF (ARKK)
ARK Innovation ETF CBOE
$83.06
-1.500 (-1.77%)
Latest Price
AI Analyst Consensus
55 / 100
ARK Innovation ETF (ARKK) is an actively managed thematic growth fund focused on disruptive innovation across various sectors. The fund's strategy centers on high-conviction holdings in companies driving advancements in areas like artificial intelligence, energy storage, and robotics. ARKK's portfolio is heavily concentrated, with Healthcare representing 28.59% and Technology 26.97% of its assets, highlighting a significant exposure to these growth-oriented industries. The fund's recent performance shows a strong 1-month return of 20.20% and a 3-year return of 25.02%, though its 1-year return of 14.07% lagged its category's 20.57%.
ARKK Price Analysis
Market Metrics
Open
$82.77
Day Range
$82.42 to $84.28
Prev Close
$84.56
Volume
5.08M
52-Week Range
$62.95 to $92.65
ARKK Fund Facts
ARK Innovation ETF is an actively managed exchange-traded fund focused on disruptive innovation. ARK Innovation ETF seeks long-term capital growth by investing primarily in domestic and foreign equity securities of companies tied to themes such as artificial intelligence, public blockchains, multiomic sequencing, energy storage, and robotics. The portfolio typically emphasizes high-conviction holdings across technology, digital assets, biotech, and other innovation-driven industries, giving it a distinct role as a thematic growth fund.
Issuer
ARK ETF Trust
Category
Mid-Cap Growth
Inception
Oct 31, 2014
Expense ratio
0.75%
Net assets
$6.44B
NAV
$86.11
Distribution yield
0.00%
YTD return
11.12%
Turnover
43.00%
Sector weights
Healthcare
28.6%
Technology
27.0%
Industrials
11.3%
Consumer Cyclical
12.5%
Financial Services
17.3%
Communication Services
3.5%
Trailing returns vs category
| Period | ARKK | Category |
|---|---|---|
| YTD | 11.12% | 4.20% |
| 1 month | 20.20% | 8.51% |
| 3 months | 4.37% | 2.79% |
| 1 year | 14.07% | 20.57% |
| 3 years | 25.02% | 14.17% |
| 5 years | -6.70% | 3.16% |
| 10 years | 16.19% | 11.45% |
Fund reference data as of Sep 11, 2026. Expense ratio and net assets are reported by the fund; returns are total returns and can differ from price change.
ARKK Analysis
AI Technical Analysis
At 49.57, ARKK's RSI is neutral, suggesting neither overbought nor oversold conditions. The ETF is currently trading below its 20-day Exponential Moving Average (EMA) of 83.64, indicating potential short-term downward pressure. However, ARKK remains above its 50-day Simple Moving Average (SMA) of 80.03 and its 200-day SMA of 77.09, suggesting that the longer-term trend is still positive. The Stochastic indicator at 11.83 points towards oversold territory, which could signal a potential rebound, while the CCI of -137.58 further supports this notion.
ProTips
- Monitor ARKK's concentration in Healthcare and Technology; diversification may be limited.
- Consider the fund's high expense ratio (0.75%) in relation to its performance.
- Given its focus on disruptive innovation, ARKK is suitable for investors with a high risk tolerance and long-term investment horizon.
Market Outlook
The 6-12 month outlook for ARKK is cautiously optimistic, contingent on the broader market's appetite for growth stocks and the continued innovation within its core sectors. While ARKK is positioned above key long-term moving averages, its recent dip below the 20-day EMA warrants monitoring for short-term weakness. A sustained recovery above the 20-day EMA would reinforce a bullish thesis, potentially targeting previous highs. Conversely, a break below the 200-day SMA could signal a more significant trend reversal, driven by macroeconomic headwinds or sector-specific challenges.
Market Correlations
How this etf moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.80
Strong correlation
Nasdaq 100 (QQQ)
+0.81
Strong correlation
Bitcoin (BTC)
+0.50
Moderate correlation
Gold (XAU)
+0.22
Weak correlation
Check Custom Correlation
Calculating correlation...
Key Statistics
| Yield | 0.4382% |
|---|---|
| Day High | $84.28 |
| Day Low | $82.42 |
| 52 Week High | 92.65 |
| 52 Week Low | 62.95 |
ARK Innovation ETF (ARKK) is actively managed by ARK Invest, focusing on disruptive innovation with significant concentration in Healthcare (28.59%) and Technology (26.97%). The fund's expense ratio is 0.75%, costing investors $75 per $10,000 invested annually. With net assets totaling $6.44 billion, ARKK is a substantial fund within its category. Its active management strategy aims for long-term capital growth by investing in companies positioned to reshape industries through technological advancements. The sector allocation indicates a strong bias towards growth-oriented themes, which can lead to higher volatility.
Earnings & Growth Analysis
Its underlying holdings are subject to earnings reports. Recent earnings data for ARKK's top holdings show mixed results. For instance, one holding reported an EPS surprise of -150% in July 2026, while another had an EPS surprise of 111.11% in December 2025. These fluctuations in earnings performance among its constituents can significantly impact the ETF's overall performance and volatility, reflecting the high-growth, high-risk nature of its investment strategy.
Key Risks
ARKK faces significant concentration risk due to its heavy weighting in Healthcare and Technology sectors, making it vulnerable to sector-specific downturns. The fund's active management style, while seeking high growth, also introduces manager risk. Also, its focus on disruptive innovation means many holdings are in earlier stages of development, carrying higher inherent volatility and potential for significant price swings.
Technical Indicators
| RSI (14) | 49.57 |
|---|---|
| MACD | 1.56 |
| SMA 50 | 80.03 |
| SMA 200 | 77.09 |
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($80.03) above the 200-day SMA ($77.09), price action is firmly bullish above key moving averages.
ARKK Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies (click to switch)
CONSERVATIVE
$82.23
Slight discount to current
Wait for small dip
AGGRESSIVE
$83.06
At current price
Enter now if confident
Risk Management
STOP LOSS
$79.16
MAX LOSS
-3.7%
Volatility-Adjusted Stop Loss
Calculated based on RSI (49.6) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$84.70
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$86.34
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$88.81
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
ETF Investment Disclaimer
This AI-generated analysis of ARKK is for educational purposes only and does not constitute investment advice. ETFs are subject to market risk including possible loss of principal. Performance depends on the underlying index or assets tracked. Read the fund prospectus before investing. Past performance does not guarantee future results. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in ARKK in September 2016 would be worth about $39,590 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ARKK today could grow to about $27,876 by 2036 in the base case, with a bull case near $145,298 and a bear case around $5,348. Projections are statistical simulations, not guarantees.
ARKK ETF Price Prediction: 2030
CleaRank's simulation projects a price near $125 for ARKK by 2030 in the base case, from $83.06 today (1.5x over 4 years). The downside path ends near $44.06. These are outcomes of a Monte Carlo simulation run on ARKK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $54.60 | $92.03 | $155 |
| 2028 | $48.73 | $102 | $213 |
| 2029 | $45.73 | $113 | $279 |
| 2030 | $44.06 | $125 | $356 |
| 2031 | $43.15 | $139 | $446 |
| 2032 | $42.77 | $154 | $552 |
| 2033 | $42.77 | $170 | $678 |
| 2034 | $43.08 | $189 | $826 |
| 2035 | $43.64 | $209 | $1,001 |
| 2036 | $44.42 | $232 | $1,207 |
Method: 10,000 simulated price paths using ARKK's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
Frequently Asked Questions
What is the expense ratio for the ARK Innovation ETF (ARKK) and what does it cost?
The ARK Innovation ETF (ARKK) has an expense ratio of 0.75%. This means that for every $10,000 invested, you would pay $75 annually in fees.
What sectors does the ARK Innovation ETF (ARKK) concentrate in?
The ARK Innovation ETF (ARKK) is primarily concentrated in Healthcare, making up 28.59% of its assets, and Technology, representing 26.97% of its holdings. Other significant allocations include Financial Services (17.25%) and Consumer Cyclical (12.45%).
How has the ARK Innovation ETF (ARKK) performed against its category over different time periods?
ARKK has shown strong performance over longer periods, with a 3-year return of 25.02% compared to its category's 14.17%. However, its 1-year return of 14.07% lagged the category's 20.57%, while its year-to-date return of 11.12% outperformed the category's 4.20%.
What is the price prediction for ARKK ETF in 2030?
Based on Monte Carlo simulations, the base case price prediction for ARKK ETF in 2030 is $125.17. The simulation also indicates a downside price of $44.06 and an upside price of $355.61. These are statistical outcomes, not guarantees.
What is the current technical outlook for ARKK?
ARKK's RSI is neutral at 49.57, and it is trading below its 20-day EMA but above its 50-day and 200-day moving averages ($80.03 and $77.09). The Stochastic indicator suggests oversold conditions, potentially signaling a near-term rebound.
What are the primary risks associated with investing in ARKK?
The primary risks for ARKK include significant concentration in the Healthcare and Technology sectors, the inherent volatility of its disruptive innovation focus, and manager risk associated with its active management strategy.
How does ARKK's strategy aim for long-term capital growth?
ARKK seeks long-term capital growth by investing in companies at the forefront of disruptive innovation, such as those in artificial intelligence, energy storage, and robotics, aiming to capitalize on transformative technological advancements.